CREATIVITY INTELLIGENTLY APPLIED
DEAD

Serial Number

76122109

Owner

EPIGENESIS Pharmaceuticals, Inc.

Attorney

VIVIANA AMZEL

Filing Date

Aug 23, 2000

Add to watchlist:

No watchlists yet
View on USPTO

CREATIVITY INTELLIGENTLY APPLIED Trademark

Serial Number: 76122109

CREATIVITY INTELLIGENTLY APPLIED is a trademark filed by EPIGENESIS Pharmaceuticals, Inc. on August 23, 2000. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

EPIGENESIS Pharmaceuticals, Inc. (26 trademarks)

2055 East Park
Cranbury, NJ 08512

Entity Type: 03

Trademark Details

Filing Date

August 23, 2000

Registration Date

Not Registered

Published for Opposition

October 22, 2002

Goods & Services

Medical diagnostic and therapeutic preparations and devices for administering same, sold filled, with diagnostic and therapeutic preparations, all for administration via diverse routes of administration including through the respiratory airways, and, medical devices for administering the pharmaceuticals, sold filled, the preparations including nucleotides, proteins and organic molecules for medical use, including macromolecules such as anti-sense oligonucleotides and enzymes and small organic and inorganic molecules for treatment of human and non-human animal respiratory, central nervous system, neoplastic, endocrine, immune and cardiovascular ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) andior inflammation, which in some cases are adenosine receptor associated symptoms; pharmaceutical preparations for testing, and preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vascoconstriction, inflammation, allergies, impeded respiration, Acute Respiratory Disease Syndrom (ARDS), renal damage and failure, ischemia resulting from the administration of certain drugs, including adenosine and other drugs for, for example, treating SupraVentricular Tachycardia (SVT), adenosine stress tests, infantile Respiratory Distress Syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vascoconstriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemias, lymphomas, carcinomas, and the like, eg colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc, as well as all metastatic cancers, eg, cancers which metastasized to the lung(s), breast, liver and prostate

Filing History

ABANDONMENT - NO USE STATEMENT FILED
Sep 25, 2003 ABN6
NOA MAILED - SOU REQUIRED FROM APPLICANT
Jan 14, 2003 NOAM
PUBLISHED FOR OPPOSITION
Oct 22, 2002 PUBO
NOTICE OF PUBLICATION
Oct 2, 2002 NPUB
Sec. 1(B) CLAIM ADDED
Jul 17, 2002 1.BA
SEC. 1(A) CLAIM DELETED
Jul 17, 2002 1.AD
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 15, 2002 CNSA
ASSIGNED TO EXAMINER
Jul 5, 2002 DOCK
EXAMINERS AMENDMENT MAILED
Jun 19, 2002 CNEA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 5, 2002 CRFA
FINAL REFUSAL MAILED
Jan 16, 2002 CNFR
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 27, 2001 CRFA
NON-FINAL ACTION MAILED
Mar 22, 2001 CNRT
ASSIGNED TO EXAMINER
Mar 8, 2001 DOCK
ASSIGNED TO EXAMINER
Feb 13, 2001 DOCK